Investment Analysis News 30 December 2025

Abbott stock today: ABT rises as Exact Sciences deal filing and Volt AFib device stay in focus

NEW YORK, December 30, 2025, 19:51 ET — After-hours Abbott Laboratories (ABT.N) shares rose 0.97% to $125.78 in Tuesday’s regular session and held steady in after-hours trading. ABT quote The move lands as investors reprice 2026 catalysts for large-cap healthcare,

31 December 2025

Healthcare Stocks·Investment Analysis·Stock Market News

Salesforce stock (CRM) slips after-hours as year-end tech trade cools and Fed minutes bite

NEW YORK, December 30, 2025, 18:23 ET — After-hours Salesforce (CRM) shares slipped 0.1% in after-hours trading on Tuesday to $265.92. The stock opened at $266.66 and traded between $265.38 and $268.21 during the regular session, with volume around 3.3

31 December 2025

Federal Reserve·Investment Analysis·Salesforce·Stock Market·Technology News

CoreWeave stock slips after-hours after insider sale filing; CRWV traders watch what comes next

NEW YORK, December 30, 2025, 17:53 ET — After-hours CoreWeave shares fell 1.4% to $73.90 in regular trading on Tuesday and slipped 0.3% after the bell to $73.70. The stock move landed as investors weighed an insider sale disclosed in

31 December 2025

After-Hours Trading·Insider Trading·Investment Analysis·Stock Market

Coinbase stock dips after-hours as Needham slashes target, flags weak crypto volumes

NEW YORK, December 30, 2025, 17:20 ET — After-hours Coinbase Global shares slipped in after-hours trading on Tuesday after Needham lowered its price target on the crypto exchange operator, pointing to a weaker outlook for trading activity. TipRanks The call

30 December 2025

Coinbase·Cryptocurrency·Financial News·Investment Analysis·Stock Market

GOOG stock steady after hours: Google’s Gemini 3 Flash push and what traders watch next

NEW YORK, December 30, 2025, 16:33 ET — After-hours Alphabet Inc’s Class C shares (GOOG), which carry no voting rights, were up 0.1% at $314.55 in after-hours trading on Tuesday, after the regular U.S. session ended at 4 p.m. ET.

30 December 2025

After Hours Trading·Artificial Intelligence·Investment Analysis·Stock Market

Why Qualys stock is sliding today: QLYS lags cybersecurity peers in late-year trade

NEW YORK, December 30, 2025, 15:41 ET — Regular session Qualys Inc shares fell 2.5% to $133.93 in afternoon trading on Tuesday, after dropping as much as 4.2% earlier in the session. The stock closed at $137.34 on Monday. The

30 December 2025

Cybersecurity·Financial Updates·Investment Analysis·Stock Market·Technology News

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

NEW YORK, December 30, 2025, 15:25 ET — Regular session Scholar Rock Holding Corp (SRRK) slid 3.2% to $43.76 in afternoon trading on Tuesday after opening at $45.18. The stock traded between $45.95 and $43.74. The move matters because Scholar

30 December 2025

Biotech News·FDA Updates·Investment Analysis·Market Trends·Stock Market

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

NEW YORK, December 30, 2025, 15:16 ET — Regular session Travere Therapeutics Inc shares were down about 3.8% at $37.39 on Tuesday afternoon, extending losses after recent insider-trading disclosures. The stock traded between $37.27 and $39.20, with about 893,000 shares

30 December 2025

Biotech Industry·FDA Approvals·Insider Trading·Investment Analysis·Stock Market News

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

NEW YORK, December 30, 2025, 14:54 ET — Regular session Shares of Praxis Precision Medicines Inc (NASDAQ: PRAX) slipped about 3% on Tuesday, giving back part of a sharp rally sparked by an FDA regulatory boost for its lead essential

30 December 2025

FDA Approvals·Healthcare Innovation·Investment Analysis·Pharmaceutical Industry·Stock Market News

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

NEW YORK, December 30, 2025, 14:50 ET — Regular session Shares of lululemon athletica inc. fell about 0.6% to $211.30 in afternoon trading on Tuesday after founder Chip Wilson launched a proxy fight — a campaign to win shareholder votes

30 December 2025

Business News·Corporate Governance·Investment Analysis·Retail Industry·Stock Market

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

NEW YORK, December 30, 2025, 14:40 ET — Regular session Shares of Cogent Biosciences, Inc. fell 2.7% to $36.88 on Tuesday after the biotech said it submitted a New Drug Application to the U.S. Food and Drug Administration for its

30 December 2025

Biotech Industry·FDA News·Investment Analysis·Pharmaceuticals·Stock Market

Schwab stock slips as Fed minutes put rate outlook back in focus

NEW YORK, December 30, 2025, 14:00 ET — Regular session The Charles Schwab Corp’s shares were down 0.6% at $100.69 in afternoon trading on Tuesday, after opening at $101.58 and trading between $100.34 and $101.60. The broader market was little

30 December 2025

Federal Reserve·Financial News·Interest Rates·Investment Analysis·Stock Market

Investment Analysis News 30 December 2025 - 31 December 2025